1. Breteler MMB. Vascular risk factors for Alzheimer's disease: an epidemiologic perspective. Neurobiol Aging. 2000. 21:153–160.
2. Launer LJ. Demonstrating the case that AD is a vascular disease: epidemiologic evidence. Ageing Res Rev. 2002. 1:61–77.
Article
3. Hofman A, Ott A, Breteler MM, Bots ML, Slooter AJ, van Harskamp F, et al. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet. 1997. 349:151–154.
Article
4. Guo Z, Qiu C, Viitanen M, Fastbom J, Winblad B, Fratiglioni L. Blood pressure and dementia in persons 75+ years old: 3-year follow-up results from the Kungsholmen Project. J Alzheimers Dis. 2001. 3:585–591.
Article
5. Johnson KA, Albert MS. Perfusion abnormalities in prodromal AD. Neurobiol Aging. 2000. 21:289–292.
Article
6. Kogure D, Matsuda H, Ohnishi T, Asada T, Uno M, Kunihiro T, et al. Longitudinal evaluation of early Alzheimer's disease using brain perfusion SPECT. J Nucl Med. 2000. 41:1155–1162.
7. Rodriguez G, Vitali P, Calvini P, Bordoni C, Girtler N, Taddei G, et al. Hippocampal perfusion in mild Alzheimer's disease. Psychiatry Res. 2000. 100:65–74.
Article
8. de la Torre JC. Is Alzheimer's disease preceded by neurodegeneration or cerebral hypoperfusion? Ann Neurol. 2005. 57:783–784.
Article
9. de la Torre JC. Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics. Lancet Neurol. 2004. 3:184–190.
Article
10. Ruitenberg A, den Heijer T, Bakker SL, van Swieten JC, Koudstaal PJ, Hofman A, et al. Cerebral hypoperfusion and clinical onset of dementia: the Rotterdam Study. Ann Neurol. 2005. 57:789–794.
Article
11. Silvestrini M, Pasqualetti P, Baruffaldi R, Bartolini M, Handouk Y, Matteis M, et al. Cerebrovascular reactivity and cognitive decline in patients with Alzheimer disease. Stroke. 2006. 37:1010–1015.
Article
12. Hetzel A, Braune S, Guschlbauer B, Dohms K. CO
2 reactivity testing without blood pressure monitoring? Stroke. 1999. 30:398–401.
Article
13. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984. 34:939–944.
Article
14. Sander K, Hof U, Poppert H, Conrad B, Sander D. Improved cerebral vasoreactivity after statin administration in healthy adults. J Neuroimaging. 2005. 15:266–270.
Article
15. Walters M, Muir S, Shah I, Lees K. Effect of perindopril on cerebral vasomotor reactivity in patients with lacunar infarction. Stroke. 2004. 35:1899–1902.
Article
16. de Leeuw FE, de Groot JC, Achten E, Oudkerk M, Ramos LM, Heijboer R, et al. Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study. J Neurol Neurosurg Psychiatry. 2001. 70:9–14.
Article
17. Heo JH, Lee YS. Measurement of cerebral vasomotor reactivity with semi-closed rebreathing method: validation study and normal reference values. J Neurol Sci. 2005. 238:supp 1. A414. Abstract.
18. Ries F, Horn R, Hillekamp J, Honisch C, Konig M, Solymosi L. Differentiation of multi-infarct and Alzheimer dementia by intracranial hemodynamic parameters. Stroke. 1993. 24:228–235.
Article
19. Reed BR, Jagust WJ, Seab JP, Ober BA. Memory and regional cerebral blood flow in mildly symptomatic Alzheimer's disease. Neurology. 1989. 39:1537–1539.
Article
20. Terborg C, Gora F, Weiller C, Rother J. Reduced vasomotor reactivity in cerebral microangiopathy: a study with near-infrared spectroscopy and transcranial Doppler sonography. Stroke. 2000. 31:924–929.
Article
21. Kidwell CS, el-Saden S, Livshits Z, Martin NA, Glenn TC, Saver JL. Transcranial Doppler pulsatility indices as a measure of diffuse small-vessel disease. J Neuroimaging. 2001. 11:229–235.
Article